Recent health news highlights key regulatory approvals and legal actions. The EU backs Novo Nordisk's Wegovy for an ...

The HBCU Week Foundation, a non-profit organization dedicated to supporting Historically Black Colleges and Universities (HBCUs), is thrilled to announce its 8th annual HBCU Week Wilmington (DE) ...

FluMist is a nasal spray manufactured by AstraZeneca that has been used to protect against influenza in the United States ...

On Friday, the Federal Trade Commission (FTC) filed a formal complaint against three major pharmacy benefit managers ...

The FDA Friday approved the flu vaccine that can be done at home and does not need to be administered by a health care provider.

The FDA is clearing the way for an at-home flu vaccines. A self-administered version of pharmaceutical giant AstraZeneca’s ...

No doctor? No problem. In a first, the US Food and Drug Administration on Friday approved a nasal spray flu vaccine for self-administration. Starting next fall, AstraZeneca's FluMist, which was ...

The U.S. Food and Drug Administration on Friday approved the first flu vaccine that comes in the form of a nasal spray and ...

The FDA authorized AstraZeneca’s treatment to be given outside a health care setting, although it will still need a prescription.

The most recent trading session ended with Astrazeneca (AZN) standing at $78.38, reflecting a -0.66% shift from the previouse trading day's closing. The stock's change was less than the S&P 500's ...

FluMist is the only flu vaccine administered by nasal spray, not injection. It is licensed for individuals between the ages ...

The latest health news covers the European Medicines Agency's approval of Novo Nordisk's Wegovy for heart conditions linked ...